Evidence map›Paper›PMID 40436982›Full record

ArticleScientific reports2025

Prevalence, reasons, and factors associated with loss to follow-up in newly diagnosed glaucoma suspects and glaucoma patients in Thailand.

Thanitta Kittisupkajorn, Isaraporn Treesit, Panhathai Yaisiri, Panrapee Funarunart

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thanitta KittisupkajornDepartment of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, 10400, Thailand.
Isaraporn TreesitDepartment of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, 10400, Thailand.
Panhathai YaisiriDepartment of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, 10400, Thailand.
Panrapee FunarunartDepartment of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, 10400, Thailand. panf81@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the prevalence and reasons for discontinuation of follow-up among newly diagnosed glaucoma suspects and glaucoma patients. Patients newly diagnosed with glaucoma suspect, primary glaucoma, and secondary glaucoma within a 2-year period who had visited the ophthalmic outpatient department and had missed an appointment by at least 6 months were identified. These patients were traced via phone call, and reasons for discontinuing follow-up and knowledge about glaucoma were retrieved. We also identified factors associated with discontinuing treatment using univariable and multivariable regression analyses. During this period, 150 out of 2,742 patients were identified as lost to follow-up, representing a prevalence rate of 5.5%. The primary reason for participants discontinuing follow-up care was a lack of knowledge and understanding about glaucoma, reported by 61.7% of participants. The second most common reason was transportation issues, reported by 18.3%. Multivariable logistic regression analysis, higher income; OR = 0.06 (0.01;0.54), awareness of glaucoma; OR = 0.18 (0.08;0.42), higher knowledge of glaucoma; OR = 0.01 (0.00;0.25) were protective factors of discontinuation of treatment.

Indexed as

GlaucomaLost to Follow-UpAdultAgedFemaleFollow-Up StudiesHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPrevalenceThailandDiscontinued treatmentFactorsGlaucomaLoss to follow-upReasons

Identifiers

PMID40436982
PMCPMC12119920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.